Entitlement offer Completed

InhaleRx entitlement offer

A$247,668 raised

Announced 26 Nov 2025 · ASX: IRX · A$0.025 cash per share

Advisers

InhaleRx

Issuer

Legal adviser

Lead managers

Not disclosed

Issuer
InhaleRx
Structure
Traditional non-renounceable entitlement offer
Completed
9 Dec 2025
Sector
Biotech and pharmaceuticals

Similar deals

All health care deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.